Oral Ketorolac for IUD Pain Reduction
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 24, 2025
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying whether taking oral ketorolac, a type of pain reliever, before getting an intrauterine device (IUD) can help reduce pain during the insertion process. The trial is specifically looking at how the timing of the medication might affect the level of pain that women experience when they have the IUD placed.
To participate in this trial, you need to be a woman aged 18 or older who wants to have an IUD inserted and is able to give consent. However, some people won’t be eligible, such as those who are currently pregnant, have certain medical conditions, or are taking specific medications that could interfere with the study. If you join the trial, you can expect to take the medication at different times before your IUD insertion, and your pain levels will be closely monitored during the procedure. The trial is not yet recruiting participants, but it aims to help improve the experience of women getting IUDs by finding effective ways to manage pain.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Able to consent
- • Desires IUD insertion
- Exclusion Criteria:
- • IUD placement under sedation or oral anxiolytic
- • IUD replacement (removal with insertion)
- • Daily narcotic or NSAID use
- • Contraindications to IUD placement
- • Current: pregnancy, genital/pelvic infection
- • Lifetime history: uterine anomaly, pelvic inflammatory disease, allergy to levonorgestrel or copper
- • Contraindications to ketorolac
- • Current: weight under 50 kilograms
- • Lifetime history: allergy to NSAIDs, liver disease, renal disease, peptic ulcer disease, cerebrovascular bleeding, gastrointestinal bleeding
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hillsborough, North Carolina, United States
Patients applied
Trial Officials
Amy G Bryant, M.D.
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported